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Injury and progressive loss of peritubular capillaries in the de-
velopment of chronic allograft nephropathy.
Background. Chronic allograft nephropathy (CAN) remains
the most important cause of late renal graft loss. However, the
mechanism for graft dysfunction and the process of the devel-
opment of CAN are not well understood. This study examined
the role of microvascular injury in the development of CAN.
Methods. We studied renal biopsies obtained from grafts with
CAN (N = 79) and pretransplant control kidneys (N = 20).
Microvascular injury was examined morphologically, and was
correlated with interstitial fibrosis, glomerular sclerosis, graft
function, and the severity of CAN. The humoral and cellular
immunity involved in CAN were examined by C4d, CD3, and
TIA-1 staining.
Results. In all the cases of CAN, microvascular injury was ev-
ident with or without CD3-positive T cells, TIA-1–positive cy-
totoxic cells, and/or C4d+ complement deposition. Irrespective
of chronic rejection (N = 14), C4d+ chronic humoral rejection
(N = 6), or other CAN, the development process of CAN was
characterized by injury and progressive loss of identifiable per-
itubular capillaries (PTCs) accompanied with the development
of interstitial fibrosis. Injured PTCs were characterized morpho-
logically by the process of angioregression with the presence of
apoptotic cells, lamination of the basement membrane, and loss
of PTCs. The low number of PTCs correlated significantly with
the severity of CAN (r = −0.74, P < 0.001), the development
of interstitial fibrosis (r = −0.75, P < 0.001), graft dysfunction
(r = −0.69, P < 0.001), and also correlated weakly with pro-
teinuria (r = −0.45, P < 0.05). In the glomeruli, capillary loss
significantly correlated with the degree of glomerular sclerosis
(r = −0.66, P < 0.001) and proteinuria (r = −0.65, P < 0.001),
but did not correlate with the severity of CAN (r = −0.24, P >
0.05) or graft dysfunction (r = −0.32, P > 0.05).
Conclusion. CAN was characterized by progressive injury to
the renal microvasculature and the development of renal scar-
ring. In particular, injury, angioregression and progressive loss
Key words: chronic allograft nephropathy, chronic rejection, C4d, inter-
stitial fibrosis, peritubular capillary, renal microvasculature, tubuloint-
erstitial injury.
Received for publication May 5, 2004
and in revised form July 9, 2004
Accepted for publication July 27, 2004
C© 2005 by the International Society of Nephrology
of the PTC network strongly contributed to the development
of interstitial fibrosis and graft dysfunction in CAN, and might
play a crucial role in the development of CAN.
As improvements are made in immunosuppressive
therapy and early allograft survival, chronic allograft
nephropathy (CAN) has become the dominant cause of
late renal allograft failure [1]. There is general agreement
that the pathogenic process of CAN is complex, and in-
volves both immunologic and nonimmunologic factors
[2–6]. A variety of alloantigen-dependent immune re-
sponses that contribute to the progression of CAN have
been reported, including prior severe rejection, subclin-
ical rejection, and chronic rejection [2–5]. Furthermore,
several alloantigen-independent immune reactions and
nonimmunologic factors, such as reperfusion-ischemic
injury, chronic cytomegalovirus and polyomavirus in-
fection, chronic toxic effects of calcineurin inhibitors,
hypertension, hyperlipidemia, and chronic vesicoureteral
reflux have also been reported, and are recognized as im-
portant causes of CAN [2–4, 6]. However, the process of
the development of CAN has not been morphologically
characterized. Moreover, the mechanism(s) for CAN re-
mains poorly understood.
The results of recent studies suggest that the renal mi-
crovasculature plays a major role in maintaining hemo-
dynamics and renal function, and that injury to the renal
microvasculature is a crucial determinant of the progres-
sive deterioration of renal function, as well as the progres-
sion of renal diseases [7–10]. Although CAN is usually
characterized by a slow progressive graft dysfunction [4],
few studies have characterized renal microvascular injury
in the development of CAN. In the present study, we in-
vestigated the process of the development of CAN using
human graft biopsies, with a special emphasis on renal
microvascular injury. We also elucidated the mechanism
for the progressive deterioration of renal function and
the development of CAN.
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METHODS
Renal biopsy
We selected 79 biopsy samples taken from grafts show-
ing CAN. Renal biopsies were performed, with informed
consent, at the time when unexplained deterioration of
the graft function or nontransient proteinuria developed.
We defined CAN as a state of impaired graft function
lasting at least 6 months post-transplant, independent
of acute rejection, overt drug toxicity, and recurrent or
de novo specific disease entities. In addition, based on
Banff’s classification [11], histopathologic examination
of the biopsy material showed chronic interstitial fibro-
sis and tubular atrophy, independent of other changes.
The histopathologic criteria for chronic rejection (CR)
were either (1) glomerular basement membrane (GBM)
duplication (chronic allograft glomerulopathy) in the ab-
sence of de novo or recurrent glomerulonephritis, or
(2) arterial intimal fibrosis (chronic allograft arteriopa-
thy) with intimal mononuclear cell infiltration [12]. The
histopathologic criteria for chronic humoral rejection
(CHR) fulfilled the histopathologic criteria for CR with
diffuse complement split product C4d deposition along
the peritubular capillaries (PTCs) [12, 13]. Renal biopsies
taken before revascularization of the transplanted kidney
(zero-hour biopsy), and samples showing no diagnos-
tic abnormality were used as controls (N = 20). Graft
function was assessed by measurement of the serum
creatinine (Cr), blood urea nitrogen (BUN), and daily
urinary protein levels (proteinuria). All patients were
treated with a conventional immunosuppression regimen
using predonisolone and cyclosporine A (CyA) or FK506
(tacrolimus) with strict blood level monitoring.
Histopathologic and immunohistochemical
examinations
Renal tissues were fixed in 10% buffered formalin,
and embedded in paraffin for light microscopic exami-
nation. Serially cut (3-lm thick) paraffin-embedded tis-
sue sections were stained with hematoxylin and eosin
(H&E), periodic acid-Schiff (PAS), Masson trichrome
(Masson), and periodic acid-methenamine (PAM) sil-
ver for histopathologic examination. The morphologic
findings evaluated by light microscopy were also charac-
terized by using electron microscopy. For electron micro-
scopic examination, the kidney tissue was fixed in 2.5%
glutaraldehyde solution in phosphate buffer (pH 7.4),
and postfixed with 1% osmium tetroxide, dehydrated,
and embedded in Epock 812. Ultrathin sections were
stained with uranyl acetate and lead citrate, and then
examined with an electron microscope (model H7100;
Hitachi Corp., Tokyo, Japan).
The following primary antibodies were used for
immunohistochemistry. Monoclonal mouse antihuman
CD34 antibody (NU-4A1; Nichrei, Tokyo, Japan), which
reacted with the surface of all endothelial cells. This anti-
body has been used as a marker for endothelial cells [14,
15]. Polyclonal goat antihuman type I collagen antibody
(Southern Biotechnology Associates, Birmingham, AL,
USA), which can detect the accumulation of collagen in
interstitial fibrosis. Monoclonal mouse antihuman type
IV collagen antibody (JK-199; Shiseido, Tokyo, Japan),
which can detect the accumulation of extracellular ma-
trix in glomeruli. Monoclonal mouse antihuman alpha-
smooth muscle actin (a–SMA) (1A4; Dako, Glostrup,
Denmark), which has been used as a marker for my-
ofibroblasts in the interstitium and activated mesangial
cells in glomeruli [16, 17]. Polyclonal rabbit antihuman
CD3 antibody (A0452; Dako), which can detect infiltrat-
ing T cells. Monoclonal mouse antihuman TIA-1 (GMP-
17) antibody (Immunotech A Coulter, Marseille Cedex,
France), which can detect infiltrating cytotoxic cells [18].
Monoclonal mouse antihuman C4d antibody (Quidel,
San Diego, CA, USA), which can detect acute and chronic
humoral rejection. The complement split product C4d,
as a stable fragment of complement degradation acti-
vated by antigen-antibody complexes, has been consid-
ered an indicator of humoral activity in allografts [12, 13,
19, 20]. For immunohistochemical staining of CD34, type
I collagen, type IV collagen, a–SMA, CD3, and TIA-1,
10% buffered formalin-fixed, paraffin-embedded tissue
sections were used, and the specimens were stained by
the standard avidin-biotin-peroxidase complex (ABC)
technique. For type I collagen, type IV collagen, and
CD3, tissue sections were incubated with 0.1% pepsin for
30 minutes and 0.1% proteinase for 5 minutes; 0.1%
pepsin for 30 minutes and 0.1% proteinase for 5 minutes;
and 0.1% pepsin for 45 minutes, respectively, before incu-
bation with the primary antibody. To detect C4d deposits
in the grafts, 4-lm thick frozen sections were stained by
the standard indirect technique and observed with a flu-
orescence microscope. For all biopsies, negative controls
were used in which the primary antibody was substi-
tuted with equivalent concentrations of an irrelevant an-
tibody or omission of antibody. All control sections were
negative.
In histologic sections, fragmented nuclear DNA associ-
ated with apoptosis was labeled by the terminal deoxynu-
cleotidyl transferase (TdT)-mediated dUTP-biotin nick
end-labeling (TUNEL) method [21]. Briefly, after sec-
tions were deparaffinized and incubated with proteinase
K, they were rinsed in TdT buffer, and then incubated
with TdT 1:25 and biotinylated-dUTP 1:20 in TdT buffer
for 60 minutes at 37◦C. The biotinylated nuclei were de-
tected with avidin-peroxidase and H2O2 containing 3,3-
diaminobenzidine tetrahydrochloride (DAB). Controls
involved omission of the dUTP or TdT in TUNEL pro-
cedures.
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Quantification of histopathologic findings
In each kidney sample, 20 randomly selected interstitial
fields (0.065 mm2), all glomerular cross-sections and all
arterial cross-sections, were assessed at ×400 for the fol-
lowing parameters: (1) PTCs, the mean number of PTC
lumina surrounded by CD34-positive cells, per intersti-
tial field; (2) interstitial fibrosis, the mean semiquanti-
tative staining score of type I collagen, per interstitial
field [22] (scores 0 to 3: score 0, no staining; score 1,
focal staining; score 2, diffuse moderate staining; score
3, diffuse strong staining); (3) glomerular capillaries, the
mean number of glomerular capillary lumina surrounded
by CD34-positive cells, per glomerular cross-section; (4)
glomerular sclerosis, the mean semiquantitative staining
score of type IV collagen, per glomerular cross-section
[23] (scores 0 to 4: score 0, no localized increase of stain-
ing; score 1, up to 25% of the glomerular tuft show-
ing focally increased staining; score 2, 25% to 50% of
the glomerular tuft demonstrating a focally, strong stain-
ing; score 3, 50% to 75% of the glomerular tuft stained
strongly in a focal manner; score 4, >75% of the glomeru-
lar tuft stained strongly). Glomerular cross-sections con-
taining only a small portion of the glomerular tuft were
excluded from the analysis, and more than 5 glomeruli
were included in each biopsy sample in the present study.
(5) Vascular occlusion, the mean semiquantitative score
of vascular fibrous intimal thickening, per arterial cross-
section [11] (scores 0 to 3: score 0, no chronic vascular
changes; score 1, vascular narrowing of up to 25% lumi-
nal area by fibrointimal thickening of arteries; score 2,
increased severity of changes described above with 26%
to 50% narrowing of vascular luminal area; score 3, severe
vascular changes with >50% narrowing of vascular lumi-
nal area). Histopathologic evaluations were performed
by 2 investigators blinded to the clinical information.
Intra and inter-observer reproducibility of the counts
of PTCs and glomerular capillaries were assessed in
selected high-power fields and selected glomeruli, respec-
tively (magnification, ×400). Repeated counts of capillar-
ies varied by less than 3% by 1 observer and 7% between
2 observers. Scores of interstitial fibrosis, glomerular scle-
rosis, and vascular occlusion did not vary by more than
3% by the single observer, or by more than 5% between
2 observers. Pearson correlations between the grading of
the severity of CAN and serum Cr levels, daily protein-
uria levels, or the duration after kidney transplantation;
serum Cr levels or daily proteinuria levels and the dura-
tion after transplantation; the score of vascular occlusion
and the grading of the severity of CAN, serum Cr lev-
els, or the duration after transplantation; the number of
PTCs and the grading of severity of CAN, the score of
interstitial fibrosis, serum Cr levels, daily proteinuria lev-
els, or the duration after transplantation; the number of
glomerular capillaries and the grading of the severity of
CAN, the score of glomerular sclerosis, serum Cr levels,
daily proteinuria levels, or the duration after transplan-
tation; and the score of interstitial fibrosis or glomeru-
lar sclerosis and the duration after transplantation, were
computed and analyzed.
RESULTS
Renal biopsies
Using Banff’s classification, the severity of CAN (N =
79) was divided into 3 grades: grade I (mild, N = 30,
38.0%); grade II (moderate, N = 27, 34.2%); and grade
III (severe, N = 22, 27.8%) (Fig. 1A to C). Patients’ char-
acteristics are summarized in Table 1. Importantly, the
grading of the severity of CAN correlated significantly
with renal dysfunction (r = 0.82, P < 0.001) (Fig. 2A). The
levels of daily proteinuria were paralleled with the grad-
ing of the severity of CAN (r = 0.44, P < 0.05) (Fig. 2B).
In the present study, 14 of 79 cases (17.8%) fulfilled the
histopathologic criteria of CR (Table 1, Fig. 1D to F). In
addition, prominent C4d deposits in the PTCs were de-
tected by immunofluorescence in 6 of 14 cases (42.9%)
that had been diagnosed as CR, and these cases were de-
fined as CHR. The proteinuria was more prominent in
CHR cases than in other CAN cases (Table 1, Fig. 2B).
CR and CHR cases tended to progress into moderate to
severe CAN within a relatively short period after trans-
plantation, accompanied with the development of pro-
teinuria and graft dysfunction (Fig. 2C to E). The arterial
occlusive lesions were often minimal in cases of CAN
without CR or CHR (Fig. 1G). The score of vascular oc-
clusion did not correlated significantly with the severity
of CAN (r = 0.34, P > 0.05), the graft dysfunction (r =
0.29, P > 0.05), or the duration after transplantation (r =
0.19, P > 0.05) (Fig. 3A to C). Typical chronic allograft
vasculopathy with intimal fibrosis and mononuclear cell
infiltration was detected mainly in CR and CHR cases
(Figs. 1E and F, 3A and B).
Microvascular injury in CAN
In all cases of CAN, various numbers of cellular infil-
trates (CD3-positive T cells and TIA-1–positive cytotoxic
cells) were seen in the renal microvasculature (PTCs and
glomerular capillaries) (Fig. 4A to C). The degree of infil-
trating CD3-positive T cells and TIA-1–positive cytotoxic
cells in the microvasculature seemed to be more promi-
nent in CR and CHR cases (data not shown). In addition,
in CHR cases, prominent C4d deposits were detected in
not only PTCs but also glomerular capillaries (Fig. 4D).
Regardless of the cases with prominent CD3-positive
and TIA-1–positive cell infiltration, CR, C4d-positive
CHR, or other CAN, microvascular (PTC and glomerular
capillary) injury was evident in all cases of CAN. A
few apoptotic dead cells were evident in the PTCs and
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Fig. 1. Morphologic changes through the progression of CAN severity (A to E, G: PAM stain; A to C, ×200; D, E, G, ×400; F, PAS stain, ×200). In
a representative case of mild CAN, the interstitium is in the process of fibrosis and eventual focal expansion (A). The glomerulus and small artery are
almost fully intact. In a representative case of moderate CAN, interstitial fibrosis and expansion present with tubular atrophy (B). The glomerulus
shows mild allograft glomerulopathy with thickening of GBM and mild expansion of the mesangial area. The small arteries show mild intimal
thickening. In a representative case of severe CAN, note the prominence of interstitial fibrosis with tubular atrophy (C). One glomerulus shows
nonspecific segmental glomerular sclerosis, and the other two show global sclerosis (arrow). The small arteries show mild intimal thickening and
chronic cyclosporine A–associated vasculopathy. Chronic allograft glomerulopathy with GBM duplication is prominent in cases with CR and CHR
(D). Chronic allograft vasculopathy of the small artery (E) and the medium-size artery (F) with arterial intimal fibrosis and intimal mononuclear cell
infiltration is detected mainly in CR and CHR cases. Evidence of tubulointerstitial fibrosis, although arterial occlusive lesions are not prominent,
in CAN cases without CR and CHR (G).
Table 1. Patients’ characteristics and summary of microvascular injury in chronic allograft nephropathy
Duration Serum Cr Interstitial Glomerular Glomerular
Age to biopsy at biopsy Proteinuria PTCs fibrosis capillaries sclerosis
N years years mg/dL g/day capillaries/field (score: 0–3) capillaries/glomerulus (score: 0–4)
CAN 79 43.4 ± 9.3 6.8 ± 4.4 3.1 ± 1.2 1.4 ± 0.9 19.9 ± 9.6 1.7 ± 0.7 54.2 ± 16.5 1.0 ± 0.7
Grade I (mild) 30 43.8 ± 9.5 6.5 ± 5.5 2.0 ± 0.4 0.9 ± 0.7 28.7 ± 8.7 0.9 ± 0.2 62.8 ± 15.2 0.9 ± 0.6
Grade II (moderate) 27 45.1 ± 10 5.9 ± 3.9 3.2 ± 0.7 1.6 ± 0.8 17.0 ± 5.0 1.8 ± 0.3 51.4 ± 13.0 0.8 ± 0.6
Grade III (severe) 22 41.1 ± 8.1 8.1 ± 2.8 4.4 ± 0.9 2.0 ± 1.1 11.4 ± 3.6 2.5 ± 0.2 46.0 ± 17.2 1.2 ± 0.7
CR 14 43.5 ± 10 5.9 ± 3.0 3.9 ± 1.0 2.2 ± 0.7 13.5 ± 5.0 2.1 ± 0.5 35.4 ± 10.1 2.4 ± 0.7
CHR 6 42.8 ± 12 5.2 ± 1.9 3.5 ± 0.3 3.1 ± 0.6 16.2 ± 5.6 2.1 ± 0.4 29.7 ± 5.7 2.8 ± 0.8
Control 20 NA NA NA NA 36.4 ± 2.4 0.1 ± 0.1 59.7 ± 5.3 0.1 ± 0.1
Abbreviations are: CAN, chronic allograft nephropathy; CR, chronic rejection; CHR, chronic humoral rejection; Control, 0 hour pretransplant control kidneys; Cr,
creatinine; NA, not available; PTCs, peritubular capillaries. Data are mean ± SD.
glomerular capillaries undergoing the process of CAN, as
judged by the TUNEL method (Fig. 4E and F), although
they were almost undetectable in the 0-hour control
biopsies. In electron microscopic studies, injured PTCs
appeared small with narrow-lumen capillaries, together
with activated endothelial cells, the detachment of en-
dothelial cells from the basement membrane (BM), and
increased lamination of the BM (Fig. 5A to D). In areas
with severe interstitial injury, PTC lumina were barely de-
tectable due to the complete loss of their original shape,
and the interstitium was widened and filled with fibrotic
material (Fig. 5E). In the glomeruli, injured capillaries
were characterized by narrow lumen and activated en-
dothelial cells with double contour, mesangial interposi-
tion, lamination, and thickening of the GBM (Fig. 5F),
similar to injured PTCs. aSMA-positive myofibroblasts
and activated mesangial cells accumulated in areas with
interstitial and glomerular injury, characterized by the
dilated interstitium and mesangial areas with loss or ab-
normal shape of capillaries (Fig. 4G and H).
PTCs and interstitial fibrosis in CAN
We examined whether PTC injury contributed to tubu-
lointerstitial scarring, graft dysfunction, and proteinuria
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Fig. 2. Correlation between CAN severity as defined by Banff’s classification and the impairment of graft function (A), the development of
proteinuria (B), or the duration after kidney transplantation (C). Also, the relationship between serum creatinine (D) and proteinuria (E) levels
to the duration after transplantation. (◦) and () indicate CR and CHR cases, respectively. The severity of CAN based on Banff’s classification
strongly correlates with graft dysfunction (r = 0.82, P < 0.001), and weakly correlates with daily proteinuria (r = 0.44, P < 0.05). However, no
correlation is evident between the duration after transplantation and the severity of CAN (r = 0.13, P > 0.05), serum Cr levels (r = 0.14, P >
0.05), or proteinuria levels (r = 0.05, P > 0.05). CR and CHR cases seem to progress into the moderate to severe CAN within a short period after
transplantation, accompanied by the development of proteinuria and graft dysfunction.
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Fig. 3. Relationship between the score of vascular occlusion (vascular fibrous intimal thickening) and the severity of CAN (A), graft dysfunction
(B), or the duration after kidney transplantation (C). () indicates the results of pretransplant control kidneys. The score of vascular occlusion does
not correlate significantly with the severity of CAN (r = 0.34, P > 0.05), the graft dysfunction (r = 0.29, P > 0.05), or the duration after kidney
transplantation (r = 0.19, P > 0.05).
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Fig. 4. Renal microvasculature injury (PTCs and glomerular capillaries) in CAN. Infiltration by CD3-positive T cells are seen in PTCs (A) and
glomerular capillaries (B) (A and B: CD3 stain, ×400). Some CD3-positive infiltrating T cells are in contact with endothelial cells in PTCs (arrow).
Infiltration by cytotoxic cells is also evident in PTCs (TIA-1 stain, ×400) (C). Immunofluorescence for C4d shows diffuse and intense staining along
PTCs (C4d stain, ×200) (D). TUNEL-positive apoptotic dead cells (arrows) are detected in PTCs (E) and glomerular capillaries (F) (TUNEL
method, ×500). a–SMA-positive interstitial myofibroblasts (G) and a–SMA-positive activated mesangial cells (H) accumulate in the dilated
interstitium and mesangial areas with the loss or abnormal shapes of capillaries (a–SMA stain, ×400).
through the progression of CAN severity. Since visual-
ization of PTCs is difficult by routine light microscopy,
PTC structures were identified using immunohistochem-
ical staining for CD34, which is known as an endothe-
lial cell marker [14, 15]. In the pretransplant control
kidneys (0 hour biopsied specimens) (Fig. 6A and E),
a well-developed PTC network was evident in contact
with the tubules and very few focal type I collagen areas
in the interstitial space. In grafts with mild CAN (Fig. 6B
and F), the CD34-positive PTC lumina appeared com-
pressed with abnormal shape due to mild expansion of
the interstitium caused by fibrosis. Focal and mild tubu-
lar atrophy was accompanied by PTC changes, and there
was an increasingly mild accumulation of type I collagen
in the interstitium. In grafts with moderate CAN (Fig. 6C
and G), the number of CD34-positive PTC lumina that
retained their original shapes were markedly decreased,
and a large part of the interstitium was expanded due to
accumulation of fibrotic materials including type I colla-
gen. Tubular atrophy was prominent in the corresponding
interstitium. In grafts with severe CAN (Fig. 6D and H),
only a few CD34-positive PTC lumina were noted; they
were displaced by fibrotic material and the lumina of the
majority of remaining PTCs were compressed, disinte-
grated, or dilated. Marked atrophy of tubules and loss of
tubular structure were prominent in the affected area of
the interstitium. Thus, more severe CAN was associated
with a greater reduction of CD34-positive PTCs (Table 1,
Fig. 6). The decrease in the number of CD34-positive
PTCs in the interstitium correlated significantly with the
grading of the severity of CAN (r = −0.74, P < 0.001),
the score of interstitial fibrosis (r = −0.75, P < 0.001),
and an increase in serum creatinine levels (r = −0.69,
P < 0.001) (Fig. 7A to C). In addition, there was a weak
correlation between the number of CD34-positive PTCs
and the development of proteinuria (r = −0.45, P < 0.05)
(Fig. 7D). However, no correlation was evident between
the number of CD34-positive PTCs and the duration af-
ter transplantation (r = −0.21, P > 0.05) (Fig. 7E). The
degree of interstitial fibrosis also did not correlate with
the duration after transplantation (r = 0.26, P > 0.05)
(Fig. 7F).
Glomerular capillaries and glomerular sclerosis in CAN
In the pretransplant 0-hour biopsies (Fig. 8A to C),
glomerular capillaries were wide open, and type IV col-
lagen was distributed in the GBM and mesangial matrix
of the glomeruli. In CR and CHR cases, chronic allograft
glomerulopathy was evident with segmental sclerosis and
diffuse thickening of the GBM (Fig. 8D). In CAN cases
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Fig. 5. Morphologic changes in the injured PTCs and glomerular capillaries. With mononuclear cell infiltration (∗) under the endothelial cell in the
PTC, note the detachment of endothelial cells from their BM (arrows) (×2000) (A). Detachment of endothelial cells from the PTC BM (arrows)
is also detected in PTCs without cell infiltration (×2000) (B). Injured capillaries are small in size with a narrow lumen and lamination of the BM
(×2500) (C). An endothelial cell (∗) is activated and swollen, and its fenestration cannot be recognized. The endothelial cell also protrudes into
the lumen of the capillary. In the fibrotic area, which is markedly atrophic, collapsed and occlusive capillaries (arrow) are still seen with marked
lamination of the BM (×2000) (D). Note the expansion of the interstitium, which is filled with fibrotic material and the loss of PTCs, evident around
tubules with interstitial fibrosis (×1000) (E). The glomerular capillary shows narrowing of the lumen with mesangial interposition and double
contour, lamination, and thickening of the GBM (×7100) (F). Also, an endothelial cell is activated with partial loss of fenestration.
without CR and CHR, glomeruli with nonspecific seg-
mental sclerosis were noted without diffuse thickening
of the GBM (Fig. 1C). In both chronic allograft glomeru-
lopathy and nonspecific segmental glomerular sclerosis,
the number of CD34-positive glomerular capillaries was
reduced within the sclerotic lesions (Fig. 8E and F). How-
ever, in cases free of CR and CHR, glomerular sclerosis
tended to be minimal even in those with severe CAN and
severe deterioration of graft function (Fig. 8G to I). Also,
the severity of the glomerular changes did not parallel the
severity of CAN (r = −0.24, P > 0.05) (Fig. 9A). The loss
of identifiable glomerular capillaries was more prominent
in CR and CHR cases than in other CAN cases (Table 1,
Fig. 9A to D). There was a significant correlation between
the number of CD34-positive glomerular capillaries and
the score of glomerular sclerosis (r = −0.66, P < 0.001)
or the development of proteinuria (r = −0.65, P < 0.001)
(Fig. 9B and D). However, there was no correlation be-
tween the number of glomerular capillaries and serum
Cr levels (r = −0.35, P > 0.05), or with the duration after
kidney transplantation (r = 0.03, P > 0.05) (Fig. 9C and
E). The degree of glomerular sclerosis also did not cor-
relate with the duration after transplantation (r = −0.04,
P > 0.05) (Fig. 9F).
DISCUSSION
In the present study, we demonstrated that, irrespec-
tive of whether CR, CHR, or other factors lead to the
328 Ishii et al: PTC injury in chronic allograft nephropathy
Fig. 6. PTCs and interstitial fibrosis through the progression of CAN severity (A to H: CD34 stain; A to D: ×400; E to H: ×600; I to L: type I
collagen stain, ×400; inset in I to L: PAM stain, ×400). In the 0-hour control kidney, PTCs are well preserved and there is little type I collagen in the
interstitium (A, E, I). In the case with mild CAN, note the low number of CD34-positive PTCs, narrow lumina, and the increase in the interstitial
area positive for type I collagen (B, F, J). In the case with moderate CAN, note the narrow lumina and the loss of PTC, together with the low number
of PTCs and the progression of interstitial fibrosis (C, G, K). In the case with severe CAN, there is severe interstitial fibrosis with accumulation of
type I collagen (D, H, L). Collapsed and a decreased number of CD34-positive PTCs are evident in the fibrotic interstitium.
development of CAN, the processes involved in its de-
velopment appear similar, and are characterized by irre-
versible injury and loss of renal microvasculature, with
the development of renal scarring. In particular, irre-
versible injury and progressive loss of PTCs seem to be
crucial events in the progression of CAN severity, as well
as chronic deterioration of graft function.
PTCs, representing a network of interstitial vessels, are
essential for maintenance of proper renal hemodynam-
ics and renal function, and for supplying oxygen to the
entire kidney [7–10]. Persistent PTC injury may directly
cause loss of PTCs [16, 24], and is also associated with an
increase in PTC pressure and an increase in postglomeru-
lar resistance, resulting in further glomerular injury and
augmentation of PTC injury [7, 25, 26]. In addition, PTC
injury triggers the release or activation (angiotensin II,
adenosine, renal sympathetic nerves) or inhibition (nitric
oxide, prostaglandin, dopamine) of vasoactive mediators
and vascular constriction, as well as reduction of PTC
plasma flow that further enhances local ischemia of the
tubules and interstitium [25, 26]. Following PTC injury,
the PTC endothelium is activated, and such a process may
correlate with the enhancement of inflammation and ac-
tivation of the coagulation system that favors further in-
terstitial and capillary injury [27–31]. Hence, PTC injury
can potentially cause localized hypoxia, chronic ischemia,
and interstitial inflammation, leading to tubular atrophy
with phenotypic changes in tubular epithelial cells, de-
velopment of interstitial injury with fibroblast activation,
and stimulation of the interstitial scarring process [9, 10,
24, 26]. Indeed, in the present study, marked interstitial
fibrosis, tubular atrophy, and consequent tubulointersti-
tial scarring were colocalized within areas of severe injury
and loss of PTCs.
Injury and loss of PTCs are also recognized in pro-
gressive renal diseases, and PTC loss may be due to both
destruction and regression of capillaries [8, 9, 32]. In re-
nal transplantation, microvascular destruction has been
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Fig. 7. Relationship between the number of CD34-positive PTC lumina and the severity of CAN (A), interstitial fibrosis (B), graft function (C),
daily proteinuria (D), or the duration after kidney transplantation (E). In the interstitium, the number of CD34-positive PTCs (capillaries/0.065
mm2 field) correlates significantly with the severity of CAN (r = −0.74, P < 0.001), the score of interstitial fibrosis (type I collagen-staining score:
0–3) (r = −0.75, P < 0.001), and with serum creatinine levels (r = −0.69, P < 0.001). The number of CD34-positive PTCs weakly correlates with
daily proteinuria levels (r = −0.45, P < 0.05). However, no correlation is evident between the number of CD34-positive PTCs and the duration
after transplantation (r = −0.21, P > 0.05). The degree of interstitial fibrosis (F) also does not correlate with the duration after transplantation (r
= 0.26, P > 0.05).
demonstrated during severe acute rejection [16, 33]. In
the present study, however, active destruction of PTCs,
characterized by capillary disruption and fragmentation
of the PTC BM and desquamation of endothelial cells,
were not evident in our CAN cases. On the other hand, in-
jured PTCs exhibited a decrease in their size with narrow-
ing of the lumina, appearance of a few TUNEL-positive
apoptotic cells, activated endothelial cells, detachment of
endothelial cells from their BM, protrusion of endothe-
lial cells into the lumen, and multilayering of the BM.
Since this structure resembles that of capillary regression
[34], we termed it “angioregression type” of injured cap-
illaries. Thus, our findings suggest that the loss of PTCs in
CAN may be ascribed to injury and subsequent angiore-
gression of PTCs. Importantly, our results indicate that
the loss of PTCs correlated significantly with the severity
of CAN, the degree of interstitial fibrosis, and the im-
pairment of graft function. These findings illustrate that
capillary regression and the loss of PTCs are essentially
involved in progressive renal dysfunction and the devel-
opment of CAN. In determining of the prognosis of CAN,
a recent study demonstrated that the quantitative mea-
surement of fibrosis by computerized image analysis ap-
pears to be a useful prognostic indicator for estimating
long-term graft function in CAN [35]. Particularly, the
cortical fractional interstitial fibrosis volume in proto-
col biopsies at 6 months’ post-transplant may provide an
early surrogate for time to graft failure in renal allograft
recipients [36]. Presently in our laboratory, a study is in
progress to examine the predictive value of the number of
PTCs in the estimation of long-term allograft outcome. In
addition, further research is necessary to understand the
mechanisms, the signaling pathway(s), and the process of
vascular regression in injured PTCs in CAN.
The phenomenon of capillary regression with apop-
tosis of endothelial cells is well described in the de-
velopment of glomerular sclerosis in progressive renal
diseases [37, 38]. In this present study, the angioregression
type of microvascular injury was also seen in glomerular
capillaries, similar to that in PTCs. The loss of glomeru-
lar capillaries correlated significantly with the degree of
glomerular sclerosis in glomeruli, with nonspecific seg-
mental sclerosis, and chronic allograft glomerulopathy. In
arteries, occlusive changes were noted mainly in CR and
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Fig. 8. Loss of glomerular capillaries and glomerular sclerosis in CAN (A, D, G: PAS stain; B, E, H: CD34 stain; C, F, I: type IV collagen stain;
A to F: ×400; G to I: ×200). In the 0-hour control kidney, the glomerulus shows well preserved glomerular capillaries without GBM thickening
or mesangial expansion and type IV collagen is distributed in the GBM and mesangial matrix (A to C). In chronic allograft glomerulopathy, the
glomerulus is sclerotic with duplicated and thickened GBM and the number of glomerular capillaries is reduced within sclerotic lesions (D to F).
Note also accumulation of type IV collagen in the sclerotic lesions and thickening of the GBM. A representative case of discrepant glomerular
changes, arterial changes, and interstitial fibrosis (G to I). In a severe CAN case, with marked deterioration of renal function (Cr 4.4 mg/dL, 14.0
years after transplantation), note the markedly low number of CD34-positive PTCs and severely fibrotic interstitium. However, the glomerulus and
the small artery (arrow) show almost fully intact architecture.
CHR cases. The presence of glomerular sclerosis, chronic
transplant glomerulopathy, or arterial occlusive lesions in
CAN suggests that these lesions probably contribute to
the development of PTC injury and the progression of
CAN [26]. However, in contrast with tubulointerstitial
fibrosis, CAN cases without CR and CHR showed rel-
atively minor glomerular sclerosis and arterial occlusive
lesions. Furthermore, the severity of glomerular and arte-
rial changes did not parallel the severity of CAN. The loss
of glomerular capillaries and the severity of vascular oc-
clusion did not correlate significantly with graft dysfunc-
tion. These findings suggest that glomerular capillary and
artery injuries may not be essential events in the devel-
opment of CAN, but rather, the loss of PTCs can lead to
CAN, independent of glomerular and large blood vessel
injury.
The pathogenesis of CAN involves a complex network
of immunologic, metabolic, and hemodynamic changes
in renal allografts [2–6]. In the present study, although
we could not determine the pathogenesis of CAN in each
case, it is likely to be multifactorial, including immuno-
logic and nonimmunologic events. Indeed, our cases in-
cluded CHR cases with C4d deposition and cases with
or without morphologic features of CR. However, the
present study demonstrated that, irrespective of CR,
CHR, or other CAN, the process of progression of CAN
severity is characterized by injury and loss of PTCs with
the development of interstitial scarring. Several stud-
ies indicated recently that the factors involved in CAN,
such as chronic cellular or chronic humoral rejection
[16], ischemia-reperfusion injury [39], cyclosporine A–
induced nephrotoxicity [40], salt-sensitive hypertension
[41], aging-associated renal injury [22, 42], and reduced
functioning renal mass [43] may facilitate renal microvas-
cular injury, especially PTC injury, ultimately resulting in
end-stage renal failure. These findings and those of the
present study suggest that the chronic immunologic and
nonimmunologic events in CAN may induce similar graft
injuries, in particular, microvascular injury. Alternatively,
since many factors involved in CAN induce similar graft
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Fig. 9. Relationship between the number of CD34-positive glomerular capillary lumina and the severity of CAN (A), glomerular sclerosis (B), graft
function (C), daily proteinuria (D), or the duration after kidney transplantation (E). In the glomerulus, the number of CD34-positive capillaries
per glomerular cross-section correlates significantly with the score of glomerular sclerosis (type IV collagen-staining score: 0–4) (r = −0.66, P <
0.001) and with the development of proteinuria (r = −0.65, P < 0.001). However, the number of glomerular capillaries does not correlate with the
severity of CAN (r = −0.24, P > 0.05), serum creatinine level (r = −0.35, P > 0.05), or with the duration after kidney transplantation (r = 0.03,
P > 0.05). The degree of glomerular sclerosis (F) also does not correlate with the duration after transplantation (r = −0.04, P > 0.05).
microvascular injury, resulting in a similar pattern of graft
pathology, it is often difficult pathologically to ascertain
the relative contribution of each factor to the develop-
ment of CAN in the biopsies. With regard to the treat-
ment of CAN, it is critically important to elucidate the
pathogenic process by examining biopsy samples to help
in the decision making regarding the early selection and
use of specific therapy before the pathologic process pro-
gresses to end-stage renal scarring [44]. However, this is
usually a very difficult task. Our results in the present
study provide evidence that CAN is characterized by a
progressive injury and loss of the renal microvasculature,
especially PTCs, together with impairment of graft func-
tion. We propose, therefore, that maintenance of the PTC
network is beneficial for the prevention of the develop-
ment of CAN, and may represent a novel therapeutic
strategy to combat progressive CAN.
CONCLUSIOIN
Microvascular injury, subsequent capillary regression,
and progressive loss of PTCs play important roles in the
development of CAN and contribute to graft dysfunction.
A careful analysis of PTC injury in biopsies is important in
the diagnosis of CAN and determination of the severity of
graft damage. Furthermore, the PTC is a potential target
for therapeutic intervention in CAN.
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